A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01)
Patent
CA 2626326
A combination of temsirolimus and herceptin in the treatment of cancer is provided. A combination of temsirolimus and HKI-272 is provided. A combination of herceptin and HKI-272 is also provided. Regimens and kits for treatment of metastatic breast cancer, containing herceptin, temsirolimus and/or HKI-272, optionally in combination with other anti-neoplastic agents, or immune modulators are described.
La présente invention concerne une combinaison de temsirolimus et d'herceptine pour le traitement du cancer. L'invention concerne plus particulièrement une combinaison de temsirolimus et de HKI-272. L'invention concerne également une combinaison d'herceptine et de HKI-272. L'invention concerne enfin des schémas posologiques et des nécessaires pour le traitement du cancer du sein métastatique, à base d'herceptine, de temsirolimus et/ou de HKI-272, éventuellement en association avec d'autres antinéoplasiques ou modulateurs immunitaires.
Moore Laurence
Rabindran Sridhar Krishna
Zacharchuk Charles
Torys Llp
Wyeth
LandOfFree
Antineoplastic combinations with mtor inhibitor, herceptin,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antineoplastic combinations with mtor inhibitor, herceptin,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antineoplastic combinations with mtor inhibitor, herceptin,... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2087880